Remifentanil

Intensive and Critical Care Nursing

Volumn 18, Issue 6, 2002, Pages 355-357

  Mason, Paula ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALFENTANIL; ESTERASE; FENTANYL; HYPNOTIC SEDATIVE AGENT; MORPHINE; MU OPIATE RECEPTOR; NARCOTIC ANALGESIC AGENT; OPIATE AGONIST; PIPERIDINE DERIVATIVE; REMIFENTANIL;

ANALGESIA; ANESTHESIA INDUCTION; ARTIFICIAL VENTILATION; BRADYCARDIA; CONTINUOUS INFUSION; DRUG ACCUMULATION; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG HYDROLYSIS; DRUG METABOLISM; DRUG SAFETY; GENERAL ANESTHESIA; HEART SURGERY; HUMAN; HYPOTENSION; INTENSIVE CARE; KIDNEY FAILURE; LICENCE; LIVER FAILURE; MUSCLE RIGIDITY; NEUROSURGERY; PATIENT CARE; RESPIRATION DEPRESSION; REVIEW; SEDATION; THORAX WALL DEFECT;

EID: 0036969092     PISSN: 09643397     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0964-3397(02)00087-3     Document Type: Review

References (2)

1. Quinton P et al. 2000 Propofol sparing effect of remifentanil when added to propofol for sedation in the intensive care unit. Intensive Care Medicine 26(supplement 3): S304
2. Kessler P et al. 2000 Remifentanil versus morphine for the provision of optimal sedation in ICU patients. Intensive Care Medicine 27(supplement 2): S239